Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boye

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Iscience|October 24, 2022
Night vision restored in days after decades of congenital blindnessSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2026
Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injectionEva Andres-Mateos, Christopher Kozlowski, Hangning Zhang, et al.
Lancet (London, England)|September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation studyPaul Yang, Laura P Pardon, Allen C Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2023
Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasionPatrick C Kellish, Damien Marsic, Sean M Crosson, et al.
Molecular Neurodegeneration|March 4, 2020
Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNSMarshall S Goodwin, Cara L Croft, Hunter S Futch, et al.
Chemical Senses|June 20, 2020
Identifying Treatments for Taste and Smell Disorders: Gaps and OpportunitiesJoel D Mainland, Linda A Barlow, Steven D Munger, et al.
Molecular Therapy. Methods & Clinical Development|April 25, 2014
Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral VectorsCharles N de Leeuw, Frank M Dyka, Sanford L Boye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 2, 2017
Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR MutationsWilliam A Beltran, Artur V Cideciyan, Shannon E Boye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2025
Current clinical applications of AAV-mediated gene therapyBarry J Byrne, Kevin M Flanigan, Susan E Matesanz, et al.
Human Gene Therapy|April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Iscience|October 24, 2022
Night vision restored in days after decades of congenital blindnessSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2026
Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injectionEva Andres-Mateos, Christopher Kozlowski, Hangning Zhang, et al.
Lancet (London, England)|September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation studyPaul Yang, Laura P Pardon, Allen C Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2023
Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasionPatrick C Kellish, Damien Marsic, Sean M Crosson, et al.
Molecular Neurodegeneration|March 4, 2020
Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNSMarshall S Goodwin, Cara L Croft, Hunter S Futch, et al.
Chemical Senses|June 20, 2020
Identifying Treatments for Taste and Smell Disorders: Gaps and OpportunitiesJoel D Mainland, Linda A Barlow, Steven D Munger, et al.
Molecular Therapy. Methods & Clinical Development|April 25, 2014
Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral VectorsCharles N de Leeuw, Frank M Dyka, Sanford L Boye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 2, 2017
Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR MutationsWilliam A Beltran, Artur V Cideciyan, Shannon E Boye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2025
Current clinical applications of AAV-mediated gene therapyBarry J Byrne, Kevin M Flanigan, Susan E Matesanz, et al.
Human Gene Therapy|April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.
Pageof 19